The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-[4-[(5-isopropyl-11-methyl-6-oxo-pyrimido[4,5-b][1,4]benzodiazepin-2-yl)amino]-3-methoxy-phenyl]methanesulfonamide ID: ALA4635720
PubChem CID: 134457649
Max Phase: Preclinical
Molecular Formula: C23H26N6O4S
Molecular Weight: 482.57
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: COc1cc(NS(C)(=O)=O)ccc1Nc1ncc2c(n1)N(C)c1ccccc1C(=O)N2C(C)C
Standard InChI: InChI=1S/C23H26N6O4S/c1-14(2)29-19-13-24-23(25-17-11-10-15(12-20(17)33-4)27-34(5,31)32)26-21(19)28(3)18-9-7-6-8-16(18)22(29)30/h6-14,27H,1-5H3,(H,24,25,26)
Standard InChI Key: YTCIFQLCJOEGBB-UHFFFAOYSA-N
Molfile:
RDKit 2D
34 37 0 0 0 0 0 0 0 0999 V2000
39.0514 -17.6547 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
39.6352 -18.2404 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
39.8496 -17.4397 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
40.4338 -18.4543 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0504 -18.8209 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
38.2560 -18.6113 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6729 -19.1934 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.8774 -18.9822 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6622 -18.1828 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.2472 -17.5984 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.0333 -16.7998 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6180 -16.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.0421 -17.8124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8636 -17.9691 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.6497 -17.1704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8451 -17.0408 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.5558 -16.2683 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0770 -15.6372 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.8815 -15.7741 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.1692 -16.5422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
34.9014 -14.8340 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
35.4819 -14.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.2681 -13.4549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2805 -14.4632 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1588 -14.4692 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1588 -13.6429 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
33.4158 -14.8141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.8130 -14.2440 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0207 -14.4824 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8327 -15.2844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4320 -15.8513 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.2238 -15.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.7299 -16.2683 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3189 -16.9823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
2 3 2 0
2 4 1 0
5 2 1 0
6 5 1 0
7 6 1 0
8 7 2 0
9 8 1 0
10 9 2 0
10 11 1 0
11 12 1 0
13 10 1 0
6 13 2 0
14 9 1 0
15 14 1 0
16 15 2 0
17 16 1 0
18 17 2 0
18 19 1 0
20 19 2 0
15 20 1 0
21 18 1 0
21 22 1 0
22 23 1 0
22 24 1 0
25 21 1 0
25 26 2 0
27 25 1 0
27 28 1 0
28 29 2 0
29 30 1 0
30 31 2 0
32 31 1 0
27 32 2 0
32 33 1 0
33 17 1 0
33 34 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 482.57Molecular Weight (Monoisotopic): 482.1736AlogP: 3.74#Rotatable Bonds: 6Polar Surface Area: 116.76Molecular Species: NEUTRALHBA: 8HBD: 2#RO5 Violations: ┄HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.57CX Basic pKa: 3.30CX LogP: 2.40CX LogD: 2.40Aromatic Rings: 3Heavy Atoms: 34QED Weighted: 0.55Np Likeness Score: -1.42
References 1. Ferguson FM, Liu Y, Harshbarger W, Huang L, Wang J, Deng X, Capuzzi SJ, Muratov EN, Tropsha A, Muthuswamy S, Westover KD, Gray NS.. (2020) Synthesis and Structure-Activity Relationships of DCLK1 Kinase Inhibitors Based on a 5,11-Dihydro-6H -benzo[e ]pyrimido[5,4-b ][1,4]diazepin-6-one Scaffold., 63 (14): [PMID:32530623 ] [10.1021/acs.jmedchem.0c00596 ]